# Foghorn Therapeutics Inc.: Form 8-K, filed Sep 1, 2021

- Company: [Foghorn Therapeutics Inc.](/companies/fhtx.md) (CIK 1822462)
- Form: 8-K
- Filed: 2021-09-01
- Accepted by EDGAR: Sep 1, 2021, 07:09 ET
- Period: 2021-08-30
- Accession: 0001628280-21-017921
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822462/000162828021017921/fhtx-20210830.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822462/000162828021017921/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1822462/000162828021017921/fhtx-20210830.htm

Filed Sep 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001628280-21-017921. Last ingested by Listed: Nov 9, 2026, 17:27 ET. No prices; not investment advice.
